In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GE Healthcare to acquire life sciences company Biacore

Executive Summary

General Electric's medical technologies division GE Healthcare has tendered a SEK3.2bn ($435mm) cash offer to acquire all outstanding shares of Swedish life sciences company Biacore, which is 41% owned by Pfizer.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
    • Biosensors
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register